
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Psychiatry and Center for Research in Diverse Populations [M. E. F.], Department of Biostatistics and Research Epidemiology [S. L. H.], Josephine Ford Cancer Center, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial [L. F.], and Cancer Epidemiology, Prevention and Control, Josephine Ford Cancer Center [C. C. J.], Henry Ford Health Sciences Center, Detroit, Michigan 48202
Objective: The study goal was to examine the effects of an initial false positive chest X-ray screening result on subsequent lung cancer screening adherence.
Methods: Adherence rates among 4705 individuals in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial at the Henry Ford Health System site with an abnormal/suspicious chest X-ray screening result in the first study year that was subsequently determined to be noncancerous (false positive result, n = 1137 exams) were compared with adherence rates among individuals with an initial negative chest X-ray screening result (n = 3568 exams).
Results: Univariate results showed a >50% increase in subsequent nonadherence among individuals with false positive screening results compared with those with negative screening results (17.2% versus 10.3% nonadherence rate, respectively; P < 0.001). Multivariable results showed that statistically significant predictors of nonadherence were false positive cases with current smoking status (P < 0.001) and false positive cases with past smoking status (P < 0.001). Additional predictors of subsequent nonadherence were being African-American (P < 0.01), being female (P < 0.001), and having a high school education or less (P < 0.01).
Conclusion: Our results demonstrate that the impact of previous screening results, smoking status, race, gender, and education on subsequent screening adherence needs to be weighed carefully, particularly for smokers, an at-risk group, when conducting lung cancer screening intervention studies and perhaps should be considered in clinical practice as well.
This article has been cited by other articles:
![]() |
P. M. McMahon, C. Y. Kong, B. E. Johnson, M. C. Weinstein, J. C. Weeks, K. M. Kuntz, J.-A. O. Shepard, S. J. Swensen, and G. S. Gazelle Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study Radiology, July 1, 2008; 248(1): 278 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Montes, L. M. Seijo, A. Campo, A. B. Alcaide, G. Bastarrika, and J. J. Zulueta Factors determining early adherence to a lung cancer screening protocol Eur. Respir. J., September 1, 2007; 30(3): 532 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Lafata, J. Simpkins, L. Lamerato, L. Poisson, G. Divine, and C. C. Johnson The Economic Impact of False-Positive Cancer Screens Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2126 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Taylor, R. Shelby, E. Gelmann, and C. McGuire Quality of Life and Trial Adherence Among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial J Natl Cancer Inst, July 21, 2004; 96(14): 1083 - 1094. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |